Exploring the Potential of Natural Compounds Against Pro-Inflammatory Cytokine Proteins Involved in Worsening COVID-19 and Against COVID-19 Proteins: An in Silico Approach
Open Access
- 30 August 2022
- journal article
- Published by Blue Eyes Intelligence Engineering and Sciences Engineering and Sciences Publication - BEIESP in International Journal of Innovative Technology and Exploring Engineering
- Vol. 11 (9), 74-98
- https://doi.org/10.35940/ijitee.g9221.0811922
Abstract
Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) is a causative agent for global pandemic disease nCOVID’19, has directed the attention of the scientific community towards the development of effective vaccines and drugs. Attempts are being made for repurposing existing drugs known for their antiviral activities, and test the traditional herbal medicines, natural compounds, nutraceuticals known for their health benefiting and immune-boosting activity against SARSCoV-2. Multidimensional approach is employed to find effective drugs against SARS-CoV2. In this study, 108 natural compounds were examined in inhibiting human protein targets which are responsible for worsening the condition of COVID-19 through a virtual screening approach. This study has screened the natural compounds 3-Hydroxydecanedioic acid, Cucurbitacin S, Diosgenin which may exhibit inhibitory activity against IL-1 receptor,IL-6 receptor respectively. It has also revealed that Dihydro-beta-ergocryptine and cucurbitacin S may exhibit inhibitory activity against TNF-alpha receptor. Further it concluded that exfoliazone shows better inhibitory activity against P38-MAPK and NF-κB pathway inhibitory proteins. These natural compounds could lead the way for future drug discovery, design and development. This will help researchers to scout new drugs in drug discovery(in-vitro and in-vivo studies).Keywords
This publication has 100 references indexed in Scilit:
- In silico prediction of the solubility advantage for amorphous drugs – Are there property-based rules for drug discovery and early pharmaceutical development?European Journal of Pharmaceutical Sciences, 2013
- Dihydroartemisinin/PiperaquineDrugs, 2012
- Carnosol: A promising anti-cancer and anti-inflammatory agentCancer Letters, 2011
- Epigallocatechin-3-gallate suppresses the global interleukin-1beta-induced inflammatory response in human chondrocytesArthritis Research & Therapy, 2011
- Inhibiting NF-κB activation by small molecules as a therapeutic strategyBiochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms, 2010
- Stigmasterol: a phytosterol with potential anti-osteoarthritic propertiesOsteoarthritis and Cartilage, 2010
- Akt-dependent NF-κB activation is required for bile acids to rescue colon cancer cells from stress-induced apoptosisExperimental Cell Research, 2009
- Theaflavin‐3‐Gallate and Theaflavin‐3′‐Gallate, Polyphenols in Black Tea with Prooxidant PropertiesBasic & Clinical Pharmacology & Toxicology, 2008
- Betulinic Acid for Cancer Treatment and PreventionInternational Journal of Molecular Sciences, 2008
- Assessment of the polyphenolic composition of the organic extracts of Mauritian black teas: A potential contributor to their antioxidant functionsBioFactors, 2006